ライフサイエンスコーパス: pluripotent

1 lls can be experimentally provoked to become pluripotent.

2 -effective assay able to distinguish between pluripotent and nonpluripotent cells.

3 ues, developmental biology remains vigorous, pluripotent, and relatively undifferentiated.

4 scle that is potentially applicable to other pluripotent cell lines and to generating other forms of

5 cells (EGCs) represent two classic types of pluripotent cell lines, yet their molecular equivalence

6 s the possibility of transitioning through a pluripotent cell state.

7 HH signaling keeps XCI in check in pluripotent cells and is transduced by GLI transcription

8 fined culture environments the properties of pluripotent cells change in an orderly sequence.

9 MEK1 was required to make Xenopus pluripotent cells competent to respond to all cell fate

10 hether endothelial cells differentiated from pluripotent cells could serve as surrogates to test emer

11 iew recent insights into the nature of human pluripotent cells in vivo, obtained by the deep sequenci

12 We differentiated pluripotent cells into either cortical or olfactory plac

13 Prematurely slowing MCM loading in pluripotent cells not only lengthens G1 but also acceler

14 the genetic regulation of gene expression in pluripotent cells.

15 required to produce cellular diversity from pluripotent cells.

16 TNF-alpha is a pluripotent cytokine that has been independently involve

17 is (SSc) by affecting the differentiation of pluripotent dermal cells.

18 molecular network that defines and restricts pluripotent developmental potential in cultured ESCs and

19 We traced heritable L1 insertions to pluripotent embryonic cells and, strikingly, to early pr

20 diversification as a fundamental property of pluripotent embryonic cells in vivo.

21 ons may therefore arise in germ cells and in pluripotent embryonic cells, prior to germline specifica

22 Utf1 is expressed in pluripotent embryonic stem (ES) cells and regulates ES c

23 In contrast, pluripotent embryonic stem (ES) cells represent an inexh

24 The capacity of pluripotent embryonic stem cells to differentiate into a

25 such as CDX2, but also for regulators of the pluripotent epiblast, including NANOG.

26 eir mRNA export activities and distinguishes pluripotent from differentiated cells.

27 we observed that expression of VEGFA and the pluripotent marker Oct-4 were also decreased.

28 , mediate reparative processes, and serve as pluripotent mesenchymal cells.

29 in resistance by inducing the expressions of pluripotent molecules Sox2 and Nanog and anti-apoptotic

30 Naive pluripotent mouse embryonic stem cells (ESCs) resemble t

31 eases L1-ORF1p levels and L1 mobilization in pluripotent mouse embryonic stem cells, implying that Te

32 rprisingly display considerable shuttling in pluripotent murine P19 cells.

33 uttle with messenger RNA to the cytoplasm in pluripotent P19 cells, but not in differentiated cells.

34 1 prevents de novo retrotransposition in the pluripotent phase of the germline cycle.

35 that tolerance induction also requires these pluripotent precursors.

36 Here we use cell fusion-mediated pluripotent reprograming to study human Xi reactivation

37 ough distinct anti-silencing activity in the pluripotent state and during PSC-differentiation for sev

38 the epigenetic memory of a somatic cell to a pluripotent state during cellular reprogramming requires

39 ly shown that E-cadherin regulates the naive pluripotent state of mouse embryonic stem cells (mESCs)

40 Gene expression heterogeneity in the pluripotent state of mouse embryonic stem cells (mESCs)

41 Our studies reveal both lineage- and pluripotent state-specific roles of polycomb repressive

42 go abrupt transitions from a naive to primed pluripotent state.

43 med prostate does not require traversal of a pluripotent state.

44 These pluripotent states have been characterized at the molecu

45 terion for the characterization of different pluripotent states, and show the relevance of transition

46 tly, epiblast cells transit through distinct pluripotent states, before lineage commitment at gastrul

47 CRISPR/Cas9 genome editing in human induced pluripotent stem (iPS) cell-derived neural progenitor ce

48 Further translational studies using induced pluripotent stem (iPS) cell-derived neuronal cells are n

49 orneal epithelium derived from human induced pluripotent stem (iPS) cells.

50 d murine HSCs with the generation of induced pluripotent stem (iPS) cells.

51 mbryonic stem (ES) cells and human inducible pluripotent stem (iPS) cells.

52 G mutation to generate heteroplasmic induced pluripotent stem cell (hiPSC) clones.

53 s from families of donors into human induced pluripotent stem cell (hiPSC) lines.

54 o establish a patient-specific human induced pluripotent stem cell (hiPSC) model of CPVT2 and to use

55 The power of human induced pluripotent stem cell (hiPSC)-based studies to resolve t

56 In RNAseq experiments of human induced pluripotent stem cell (iPSC) derived cardiomyocytes trea

57 ificantly improves the efficiency of induced pluripotent stem cell (iPSC) generation by the Yamanaka

58 type and mutant RTT patient-specific induced pluripotent stem cell (iPSC) line carrying the V247fs mu

59 is study, we derived a collection of induced pluripotent stem cell (iPSC) lines capturing a range of

60 We created induced pluripotent stem cell (iPSC) lines from 1 patient with t

61 ne expression profiling of 215 human induced pluripotent stem cell (iPSC) lines from different donors

62 three C1 replicates from three human induced pluripotent stem cell (iPSC) lines.

63 in three wild-type (WT) and three HD induced-pluripotent stem cell (iPSC) lines.

64 Human-induced pluripotent stem cell (iPSC) technology offers a novel p

65 ten the action potential duration in induced pluripotent stem cell (iPSC)-derived cardiomyocytes from

66 d the therapeutic potential of human induced pluripotent stem cell (iPSC)-derived cells at two differ

67 related genetic mutations in patient induced pluripotent stem cell (iPSC)-derived DAergic neurons and

68 We studied induced-pluripotent stem cell (iPSC)-derived megakaryocytes (iMe

69 In neuropathology research, induced pluripotent stem cell (iPSC)-derived neurons are conside

70 he innate immune properties of human induced-pluripotent stem cell (iPSC)-derived RPE cells, particul

71 ables organ-specific enrichment of xenogenic pluripotent stem cell (PSC) derivatives.

72 Through pluripotent stem cell (PSC) technology, human intestinal

73 several groups pursuing clinical trials with pluripotent stem cell (PSC)-derived dopamine neurons.

74 LA) class I genes can cause the rejection of pluripotent stem cell (PSC)-derived products in allogene

75 velopmental genes during the G1 phase of the pluripotent stem cell cycle contributes to cell fate dec

76 Human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs)

77 les and genetic screens, or applied to human pluripotent stem cell differentiation for beta-like cell

78 unique molecular mechanisms underlying human pluripotent stem cell differentiation into late primordi

79 ed from multiple human embryonic and induced pluripotent stem cell lines and have potential applicati

80 ain cell fates, our fragile X syndrome human pluripotent stem cell lines exhibited reproducible aberr

81 ing large-scale collections of human induced pluripotent stem cell lines provide valuable insight int

82 more common in ES cell lines than in induced pluripotent stem cell lines.

83 Here we show, using murine and human induced pluripotent stem cell models, that RPGR interacts with a

84 mechanism for controlling the make-up of the pluripotent stem cell population.

85 ociation Studies Consortium has used induced pluripotent stem cell technology to study the effects of

86 Here, the authors use a human pluripotent stem cell-based model, termed the post-impla

87 Here the authors apply a human pluripotent stem cell-based platform to study the effect

88 otent stem cells to generate a human-induced pluripotent stem cell-derived cardiac muscle patch (hCMP

89 ell device for functional screening in human pluripotent stem cell-derived cardiac organoids (hCOs).

90 onization within maturing, unlabeled induced pluripotent stem cell-derived cardiomyocyte cultures.

91 RATIONALE: Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM)

92 nd decreased beat amplitude in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

93 In human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

94 l studies of drug effects with human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

95 s to generate EHM from embryonic and induced pluripotent stem cell-derived cardiomyocytes and fibrobl

96 ed that commercially available human induced pluripotent stem cell-derived cardiomyocytes are a power

97 o supports the use of isogenic human induced pluripotent stem cell-derived cardiomyocytes as a physio

98 The patient-derived induced pluripotent stem cell-derived cardiomyocytes display (1)

99 electrophysiological maturation of the human pluripotent stem cell-derived cardiomyocytes in our syst

100 d in rodent cardiomyocytes and human induced pluripotent stem cell-derived cardiomyocytes in vitro an

101 sion produced a functional rescue in induced pluripotent stem cell-derived cardiomyocytes with D130G-

102 eded with approximately 50 000 human-induced pluripotent stem cell-derived cardiomyocytes, smooth mus

103 Using human induced pluripotent stem cell-derived cardiomyocytes, we not onl

104 ole of TLR3-IFN immunity using human induced pluripotent stem cell-derived cardiomyocytes.

105 tro models, such as isolated adult and human pluripotent stem cell-derived cardiomyocytes; (2) 2-dime

106 yocyte monolayers or small clusters of human pluripotent stem cell-derived cardiomyocytes; (3) 3-dime

107 Human and mouse pluripotent stem cell-derived CMs (PSC-CMs) were transdu

108 rat ventricular myocytes, and human induced pluripotent stem cell-derived CMs, decreasing expression

109 Transplantation of human pluripotent stem cell-derived dopaminergic neurons is a

110 ls, patient-derived fibroblasts, and induced pluripotent stem cell-derived dopaminergic neurons.

111 Here, we used comparison of induced pluripotent stem cell-derived endothelial cells (iPSC-EC

112 n the lung, our study indicates that induced pluripotent stem cell-derived endothelial cells are usef

113 Native pulmonary arterial and induced pluripotent stem cell-derived endothelial cells from pat

114 xytoluene, in endocrine-active human-induced pluripotent stem cell-derived foregut epithelial cells a

115 ed the BM homing properties of human induced pluripotent stem cell-derived HSPCs (hiPS-HSPCs).

116 e in patient-derived fibroblasts and induced pluripotent stem cell-derived motor neurons.

117 H-SY5Y neuroblastoma cells and human induced pluripotent stem cell-derived motor neurons.

118 Induced pluripotent stem cell-derived neural stem cells (iNSCs)

119 Similarly, induced pluripotent stem cell-derived neurons from a patient car

120 logy of mice hippocampal neurons and induced pluripotent stem cell-derived neurons from a patient car

121 the underlying pathophysiology using induced pluripotent stem cell-derived neurons from AS patients a

122 kdown of Parkin or SLP-2, as well as induced pluripotent stem cell-derived neurons from Parkin mutati

123 agy, which is also apparent in human induced pluripotent stem cell-derived neurons, a disease-relevan

124 , but also exacerbated cell death in induced pluripotent stem cell-derived primary human neurons unde

125 stablished conditions by which human induced pluripotent stem cell-derived sensory neurons can be cul

126 expressed in either rodent or human induced pluripotent stem cell-derived sensory neurons in vitro p

127 Myelinating co-cultures using human induced pluripotent stem cell-derived sensory neurons thus provi

128 Treatment of patient-derived induced pluripotent stem cell-hepatic cells with a JNK inhibitor

129 tipotent (mesenchymal and hematopoietic) and pluripotent stem cells (embryonic and induced) for regen

130 of cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs), 41 were accurately q

131 o generate cardiomyocytes from human induced pluripotent stem cells (hiPSCs) and human embryonic stem

132 Human induced pluripotent stem cells (hiPSCs) are invaluable to study

133 Human-induced pluripotent stem cells (hiPSCs) can be differentiated in

134 dye transfer assay showed that human induced pluripotent stem cells (hiPSCs) contained functional gap

135 ac tissue (LF-ECT) composed of human induced pluripotent stem cells (hiPSCs) derived multiple lineage

136 We report the derivation of human-induced pluripotent stem cells (hiPSCs) from patients with diagn

137 Genome editing of human induced pluripotent stem cells (hiPSCs) offers unprecedented opp

138 cardiomyocyte development from human induced pluripotent stem cells (hiPSCs).

139 al human beige adipocytes from human induced pluripotent stem cells (hiPSCs).

140 cells in vitro, including from human induced pluripotent stem cells (hiPSCs).

141 Human pluripotent stem cells (hPS cells) can self-renew indefi

142 the generation of beta-like cells from human pluripotent stem cells (hPSC).

143 an be successfully differentiated from human pluripotent stem cells (hPSCs) and hold the potential to

144 Human pluripotent stem cells (hPSCs) are adhesion-dependent ce

145 As human pluripotent stem cells (hPSCs) exit pluripotency, they a

146 Cardiomyocyte creation by human pluripotent stem cells (hPSCs) has generated opportuniti

147 ar pluripotency and differentiation in human pluripotent stem cells (hPSCs) has yet to be systematica

148 testinal organoids differentiated from human pluripotent stem cells (hPSCs) have revolutionized the s

149 We differentiated human pluripotent stem cells (hPSCs) into gastric organoids co

150 strate the capability to differentiate human pluripotent stem cells (hPSCs) into kidney structures.

151 ation of hematopoietic stem cells from human pluripotent stem cells (hPSCs) is a major goal for regen

152 Human pluripotent stem cells (hPSCs) provide a valuable model

153 ssion level, we genetically engineered human pluripotent stem cells (hPSCs) to express various N-term

154 lumenal epiblast-like morphogenesis of human pluripotent stem cells (hPSCs).

155 Technology utilizing human induced pluripotent stem cells (iPS cells) has enormous potentia

156 In recent years, rapid emergence of induced pluripotent stem cells (iPSC) and iPSC-derived cardiomyo

157 ate oligodendrocytes (OL) from human induced pluripotent stem cells (iPSC) are currently lacking, but

158 Donor-specific induced pluripotent stem cells (iPSC) can be used to generate de

159 We have generated induced pluripotent stem cells (iPSC) from five HLHS patients an

160 report the differentiation of human induced pluripotent stem cells (iPSC) into microglia-like cells

161 complex (TSC) and LAM (TSC-LAM) into induced pluripotent stem cells (iPSC), followed by selection of

162 d body (EB) cells] from primed-state induced pluripotent stem cells (iPSCs) after a 72-hour transient

163 Two recent technologies, induced-pluripotent stem cells (iPSCs) and direct somatic reprog

164 complex processes: reprogramming to induced pluripotent stem cells (iPSCs) and hematopoiesis.

165 1) and used their tissue to generate induced pluripotent stem cells (iPSCs) and hepatocyte-like cells

166 Here, we used induced pluripotent stem cells (iPSCs) and neural progenitor cel

167 Induced pluripotent stem cells (iPSCs) are an essential tool for

168 Induced pluripotent stem cells (iPSCs) are being pursued as a so

169 Human induced pluripotent stem cells (iPSCs) are ideal cell sources fo

170 ntotemporal dementia patient-derived induced pluripotent stem cells (iPSCs) carrying the Tau P301L mu

171 Human induced pluripotent stem cells (iPSCs) derived from individuals

172 murine and human retinoblastomas and induced pluripotent stem cells (iPSCs) derived from murine rod p

173 Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) efficiently generate all

174 We generated and characterized induced pluripotent stem cells (iPSCs) from ALS patients with di

175 In this study, we generated induced pluripotent stem cells (iPSCs) from AML patient samples

176 We generated induced pluripotent stem cells (iPSCs) from control individuals

177 Here we generated de novo induced pluripotent stem cells (iPSCs) from patients harboring t

178 opment, the present study used human induced pluripotent stem cells (iPSCs) from RTT and control indi

179 Genome integrity of induced pluripotent stem cells (iPSCs) has been extensively stud

180 Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) holds enormous promise fo

181 n leukocyte antigen (HLA)-homozygous-induced pluripotent stem cells (iPSCs) is considered a future cl

182 ramming of differentiated cells into induced pluripotent stem cells (iPSCs) is usually achieved by ex

183 Induced pluripotent stem cells (iPSCs) show variable methylation

184 w that astrocytes derived from human induced pluripotent stem cells (iPSCs) support the replication o

185 ed on a genetically diverse panel of induced pluripotent stem cells (iPSCs) that reproduces susceptib

186 variants through differentiation of induced pluripotent stem cells (iPSCs) to study cellular pathoph

187 Steering the differentiation of induced pluripotent stem cells (iPSCs) toward specific cell type

188 ganoids derived from control and MDS-induced pluripotent stem cells (iPSCs) using time-lapse imaging,

189 Induced pluripotent stem cells (iPSCs) were generated from one u

190 s derived from schizophrenia patient induced pluripotent stem cells (iPSCs) with a DISC1 mutation tha

191 of functional airway organoids from induced pluripotent stem cells (iPSCs) would provide valuable mo

192 Induced pluripotent stem cells (iPSCs), and cells derived from t

193 knockdown neuroblastoma cell lines, induced pluripotent stem cells (iPSCs), and iPSC-derived cortica

194 We show that during reprogramming to induced pluripotent stem cells (iPSCs), fibroblasts from sterile

195 blished a liver organoid using human induced pluripotent stem cells (iPSCs), mesenchymal stem cells (

196 Using patient-specific induced pluripotent stem cells (iPSCs), we generated MCT8-defici

197 , stem cells as well as reprogrammed induced pluripotent stem cells (iPSCs), where the protein can al

198 six transformed cell lines and human induced pluripotent stem cells (iPSCs).

199 characteristics can be produced from induced pluripotent stem cells (iPSCs).

200 (OSKM) reprograms somatic cells into induced pluripotent stem cells (iPSCs).

201 uman embryonic stem cells (hESCs) or induced pluripotent stem cells (iPSCs).

202 and clinical interest, such as human induced pluripotent stem cells (iPSCs).

203 using macrophages derived from human induced pluripotent stem cells (iPSdMs) to study macrophage-Chla

204 Patient-specific pluripotent stem cells (PSCs) can be generated via nucle

205 Human pluripotent stem cells (PSCs) exist in naive and primed

206 stem and progenitor cells (HSPCs) from human pluripotent stem cells (PSCs) has been a long-sought-aft

207 Pluripotent stem cells (PSCs) have major potential as an

208 opmentally differentiated NKX2-1GFP reporter pluripotent stem cells (PSCs) in vitro to generate and i

209 Approaches to differentiating pluripotent stem cells (PSCs) into neurons currently fac

210 The generation of T cells from pluripotent stem cells (PSCs) is attractive for investig

211 neered by either directed differentiation of pluripotent stem cells (PSCs) or direct conversion, and

212 Human pluripotent stem cells (PSCs) provide a unique entry to

213 Of all known cultured stem cell types, pluripotent stem cells (PSCs) sit atop the landscape of

214 The in vitro-directed differentiation of pluripotent stem cells (PSCs) through stimulation of dev

215 tion has focussed on the conversion of human pluripotent stem cells (PSCs) to a more naive developmen

216 ineering approach with embryonic and induced pluripotent stem cells (PSCs) to generate human intestin

217 sis of BMP4-induced differentiation of human pluripotent stem cells (PSCs) toward progeny with trophe

218 novo methylation of the entire CGI in human pluripotent stem cells (PSCs).

219 pitulating skeletal myogenesis in vitro from pluripotent stem cells (PSCs).

220 plications of hepatocytes derived from human pluripotent stem cells and challenges to using these cel

221 generated a genetic model of PKD using human pluripotent stem cells and derived kidney organoids.

222 Dividing cells called neoblasts contain pluripotent stem cells and drive planarian flatworm rege

223 aematopoietic stem and progenitor cells from pluripotent stem cells and holds promise for modelling h

224 viously unrecognized fate potential of human pluripotent stem cells and provides a platform for advan

225 The induced pluripotent stem cells approach allows comparison betwee

226 Endothelial cells derived from human pluripotent stem cells are a promising cell type for enh

227 ferentiation of four patient-derived induced pluripotent stem cells as a model for the onset of proge

228 cells can be successfully reprogrammed into pluripotent stem cells by the ectopic expression of defi

229 Induced pluripotent stem cells could potentially help to elucida

230 K293 cells and also overexpressed in induced pluripotent stem cells derived cardiomyocytes (iPSCs-CM)

231 nable its wide application in phenotyping of pluripotent stem cells for large scale stem cell culture

232 A4 was interrupted by CRISPR-Cas9 in induced pluripotent stem cells from healthy donors.

233 Using motor neurons derived from induced pluripotent stem cells from patients with ALS and FUS mu

234 neural progenitor cells derived from induced pluripotent stem cells from schizophrenia patients with

235 ds of access to and quality of human induced pluripotent stem cells has lagged behind their use.

236 Pluripotent stem cells have broad utility in biomedical

237 Induced pluripotent stem cells have great potential as a human m

238 s-enduring cells were identified as distinct pluripotent stem cells in mesenchymal cell populations i

239 progenitors (PPs) can be derived from human pluripotent stem cells in vitro but efficiency of differ

240 s and organoids have been derived from human pluripotent stem cells in vitro, but generating a human

241 nerate functional beta-like cells from human pluripotent stem cells in vitro, including from human in

242 cells (HSCs) could be generated from induced pluripotent stem cells in vitro.

243 is sufficient to differentiate human induced pluripotent stem cells into electrophysiologically activ

244 morphogen-directed differentiation of human pluripotent stem cells into haemogenic endothelium follo

245 factors can direct differentiation of human pluripotent stem cells into organoids - aggregates with

246 Technologies to differentiate human pluripotent stem cells into three-dimensional organized

247 s from human embryonic stem cells or induced pluripotent stem cells is at present close to reality, a

248 et al. (2017) investigate mechanisms for how pluripotent stem cells maintain their identity during ce

249 The advent of induced pluripotent stem cells means that it may ultimately be p

250 ancreatic endocrine cells derived from human pluripotent stem cells mimics key in vivo events.

251 ndromic autism pathophysiology using induced pluripotent stem cells modeling disease technology.

252 broblasts, embryonic stem cells, and induced pluripotent stem cells of laboratory rats.

253 evertheless, to our knowledge, miRNAs in the pluripotent stem cells of one of the most commonly used

254 ty to propagate mature cells and tissue from pluripotent stem cells offers enormous promise for treat

255 Human pluripotent stem cells provide a potential source for ph

256 Differentiation of human pluripotent stem cells recapitulates development of the

257 d differentiation of patient-derived induced pluripotent stem cells showed a reduced expansion of lym

258 ion of arterial endothelial cells from human pluripotent stem cells that exhibit arterial-specific fu

259 erate three-dimensional spheroids from human pluripotent stem cells that resemble either the dorsal o

260 m with NPCs and neurons derived from induced pluripotent stem cells to create patient-specific cellul

261 t had been differentiated from human-induced pluripotent stem cells to generate a human-induced pluri

262 We used fibroblast-derived induced pluripotent stem cells to generate retinal pigment epith

263 For example, attempts to differentiate human pluripotent stem cells to lung epithelium rely on passin

264 Applying Expedition to single pluripotent stem cells undergoing neuronal differentiati

265 Induced pluripotent stem cells were derived from a clinically we

266 Whole-genome sequencing and induced pluripotent stem cells were used to examine a family wit

267 ted CSC-like cells by treating mouse induced pluripotent stem cells with conditioned medium from brea

268 at human cardiomyocytes derived from induced pluripotent stem cells with enhanced expression of isofo

269 th human cardiomyocytes derived from induced pluripotent stem cells with enhanced Kir2.1 expression a

270 ngs constitute a first step toward capturing pluripotent stem cells with extraembryonic developmental

271 to a selection of biological systems: human pluripotent stem cells with their cardiac derivatives, m

272 an extra human chromosome and human induced pluripotent stem cells with trisomy 21, as well as cance

273 nterferes with neural specification of human pluripotent stem cells, a process equating to the earlie

274 itates the generation of more robust induced pluripotent stem cells, characterized by enhanced plurip

275 of Nudt21 enhanced the generation of induced pluripotent stem cells, facilitated transdifferentiation

276 ming by transcription factors (i.e., induced pluripotent stem cells, iPSCs) or by somatic cell nuclea

277 2 hiPSC lines and 2 hESC lines at 4 stages: pluripotent stem cells, mesoderm, cardiac mesoderm, and

278 reprogrammed fibroblasts to generate induced pluripotent stem cells, neural progenitor cells (NPCs) a

279 human neural progenitor cells, human induced pluripotent stem cells, or in primary rat cortical neuro

280 nto three domains: the lineage commitment of pluripotent stem cells, the appropriation of primordial

281 expands the developmental potential of mouse pluripotent stem cells, yielding both embryonic and extr

282 n both mouse mesencephalic and human induced pluripotent stem cells-derived DA neurons.

283 et production by megakaryocytes derived from pluripotent stem cells.

284 specific cell populations derived from human pluripotent stem cells.

285 mouse embryonic stem cells and human induced pluripotent stem cells.

286 al layers of global gene regulation in human pluripotent stem cells.

287 eprogramming somatic cells to become induced pluripotent stem cells.

288 ing sites in NPCs are largely preexisting in pluripotent stem cells.

289 procedures that yield low numbers of induced pluripotent stem cells.

290 ls of human disease to be generated-e.g., in pluripotent stem cells.

291 s of the miR-200 family, was detected in rat pluripotent stem cells.

292 generating chamber-specific cell types from pluripotent stem cells.

293 e in single embryonic stem cells and induced pluripotent stem cells.

294 on of mouse embryonic stem cells and induced pluripotent stem cells.

295 us-specific DNA demethylation in somatic and pluripotent stem cells.

296 an neural progenitor cells and human induced pluripotent stem cells.

297 tion of embryonic-like structures from human pluripotent stem cells.

298 histone modifications, are a key property of pluripotent stem cells.

299 we demonstrate that the epithelium of human pluripotent stem-cell-derived human intestinal organoids

300 Well-characterized human pluripotent stem-cell-derived ventricular cardiomyocytes